Long-Term Durability of Percutaneous Transluminal Angioplasty in Patients with Symptomatic Middle Cerebral Artery Stenosis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and PurposeaaPercutaneous transluminal angioplasty (PTA) is being increasingly used in the treatment of symptomatic middle cerebral artery (MCA) stenosis. We evaluated the long-term durability after PTA for symptomatic MCA stenosis. MethodsaaWe analyzed consecutive patients included in our stroke database who were treated with angioplasty alone. The subjects without major periprocedural complications were followed up for at least 42 months. Recurrent ischemic symptoms were defined as newly developed episodes of transient ischemic attack or ischemic stroke in the territory of the treated vessel. Stroke was defined as ischemic stroke in any vessel. ResultsaaPTA was technically successful in 37 of the 40 included patients. Thirty-two of the 37 patients were followed up at regular intervals of 1 to 6 months in the outpatient clinic of our institution for at least 42 months. Restenosis occurred in 3 of the 32 patients (9.4%) within 2 years of PTA, and no restenosis was identified thereafter. Two of the three patients with restenosis had asymptomatic complications such as dissection and vasospasm during the intervention. The ischemic area was in the treated vessel in 1 of the 32 patients and in other vessels in 3 of the 32 patients (9.4%). ConclusionsaaSuccessful PTA can result in a low rate of recurrent ischemic symptoms, and restenosis during a long-term follow-up appears to be more frequent in the early period.
Abstract
Background and PurposeaaPercutaneous transluminal angioplasty (PTA) is being increasingly used in the treatment of symptomatic middle cerebral artery (MCA) stenosis. We evaluated the long-term durability after PTA for symptomatic MCA stenosis. MethodsaaWe analyzed consecutive patients included in our stroke database who were treated with angioplasty alone. The subjects without major periprocedural complications were followed up for at least 42 months. Recurrent ischemic symptoms were defined as newly developed episodes of transient ischemic attack or ischemic stroke in the territory of the treated vessel. Stroke was defined as ischemic stroke in any vessel. ResultsaaPTA was technically successful in 37 of the 40 included patients. Thirty-two of the 37 patients were followed up at regular intervals of 1 to 6 months in the outpatient clinic of our institution for at least 42 months. Restenosis occurred in 3 of the 32 patients (9.4%) within 2 years of PTA, and no restenosis was identified thereafter. Two of the three patients with restenosis had asymptomatic complications such as dissection and vasospasm during the intervention. The ischemic area was in the treated vessel in 1 of the 32 patients and in other vessels in 3 of the 32 patients (9.4%). ConclusionsaaSuccessful PTA can result in a low rate of recurrent ischemic symptoms, and restenosis during a long-term follow-up appears to be more frequent in the early period.
참고문헌 (17)
- Chimowitz MI, "Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis", N Engl J Med, 352, pp.1305~1316 (2005)
- Sacco RL, "Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The northern Manhattan stroke study", Stroke, 26, pp.14~20 (1995)
- SSYLVIA Study Investigators, "Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA): study results", Stroke, 35, pp.1388~1392 (2004)
- Chimowitz MI, "The warfarin-aspirin symptomatic intracranial disease study", Neurology, 45, pp.1488~1493 (1995)
- Thijs VN, "Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy", Neurology, 55, pp.490~497 (2000)
- Mori T, "Percutaneous transluminal cerebral angioplasty: serial angiographic follow-up after successful dilatation", Neuroradiology, 39, pp.111~116 (1997)
- Alazzaz A, "Intracranial percutaneous transluminal angioplasty for arteriosclerotic stenosis", Arch Neurol, 57, pp.1625~1630 (2000)
- Mazighi M, "Durability of endovascular therapy for symptomatic intracranial atherosclerosis", Stroke, 39, pp.1766~1769 (2008)
- Yoon W, "Symptomatic middle cerebral artery stenosis treated with intracranial angioplasty: experience in 32 patients", Radiology, 237, pp.620~626 (2005)
- Kappelle LJ, "Importance of intracranial atherosclerotic disease in patients with symptomatic stenosis of the internal carotid artery. The north American symptomatic carotid endarterectomy trail", Stroke, 30, pp.282~286 (1999)
- Demchuk AM, "Specific transcranial Doppler flow findings related to the presence and site of arterial occlusion", Stroke, 31, pp.140~146 (2000)
- Demchuk AM, "Accuracy and criteria for localizing arterial occlusion with transcranial Doppler", J Neuroimaging, 10, pp.1~12 (2000)
- Arenillas JF, "Progression and clinical recurrence of symptomatic middle cerebral artery stenosis: a long-term follow-up transcranial Doppler ultrasound study", Stroke, 32, pp.2898~2904 (2001)
- Wojak JC, "Intracranial angioplasty and stenting: long-term results from a single center", AJNR Am J Neuroradiol, 27, pp.1882~1892 (2006)
- Fiorella D, "A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease", Neurosurgery, 61, pp.236~242 (2007)
- Lee JH, "Percutaneous transluminal angi-oplasty for symptomatic middle cerebral artery stenosis: long-term follow-up", Cerebrovasc Dis, 15, pp.90~97 (2003)
- Marks MP, "Outcome of angioplasty for atherosclerotic intracranial stenosis", Stroke, 30, pp.1065~1069 (1999)